title: Extensive acute toxic leukoencephalopathy induced by fludarabine: two months follow-up on brain MRI.
authors.affiliation: Department of diagnostic and therapeutic neuroimaging, Pellegrin hospital, place Amélie-Raba-Léon, 33000 Bordeaux, France. Electronic address: amandine.crombe@ens-lyon.fr.
authors.forename: Amandine
authors.initials: A
authors.lastname: Crombe
authors.affiliation: Department of radiology, Saint-André hospital, 1, rue Jean-Burguet, 33000 Bordeaux, France.
authors.forename: Nicolas
authors.initials: N
authors.lastname: Alberti
authors.affiliation: Department of ophtalmology, Pellegrin hospital, place Amélie-Raba-Léon, 33000 Bordeaux, France.
authors.forename: Marion
authors.initials: M
authors.lastname: Gilles
authors.affiliation: Department of hematology, Haut-Leveque hospital, 1, avenue Magellan, 33600 Pessac, France.
authors.forename: Alexandre
authors.initials: A
authors.lastname: Guy
authors.affiliation: Department of diagnostic and therapeutic neuroimaging, Pellegrin hospital, place Amélie-Raba-Léon, 33000 Bordeaux, France.
authors.forename: Elise
authors.initials: E
authors.lastname: De Roquefeuil
authors.affiliation: Department of diagnostic and therapeutic neuroimaging, Pellegrin hospital, place Amélie-Raba-Léon, 33000 Bordeaux, France.
authors.forename: Vincent
authors.initials: V
authors.lastname: Dousset
authors.affiliation: Department of diagnostic and therapeutic neuroimaging, Pellegrin hospital, place Amélie-Raba-Léon, 33000 Bordeaux, France.
authors.forename: Thomas
authors.initials: T
authors.lastname: Tourdias
mesh_terms: D000970:Antineoplastic Agents / Q000009:adverse effects; D001921:Brain / Q000187:drug effects / Q000473:pathology*; D003937:Diagnosis, Differential; D038524:Diffusion Magnetic Resonance Imaging / Q000379:methods*; D005500:Follow-Up Studies; D006801:Humans; D007938:Leukemia / Q000150:complications / Q000188:drug therapy / Q000473:pathology; D056784:Leukoencephalopathies / Q000139:chemically induced* / Q000473:pathology* / Q000517:prevention & control; D008297:Male; D008875:Middle Aged; D016896:Treatment Outcome; D014740:Vidarabine / Q000009:adverse effects / Q000031:analogs & derivatives*
chemical_list: D000970:Antineoplastic Agents; D014740:Vidarabine; C024352:fludarabine